A Clinical Study of Allogeneic CD19/BCMA CAR-T Cells for the Treatment of R/R B-cell Malignant Tumors

NCT06976437 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

21

Enrollment

OTHER

Sponsor class

Conditions

B Cell Lymphoma
Multiple Myeloma

Interventions

DRUG: RN1101 injection

Sponsor

YANRU WANG

Collaborators

[object Object]
[object Object]